Top Tweets for #ppwebinar
Rare disease care is evolving! Learn how CGT is tackling unmet needs and advancing treatments in this free webinar, sponsored by @IPGHealth.
📅 5th March 3pm GMT
Register: https://t.co/OROzRjxBCf
#raredisease #ppwebinar
How can #pharmamarketers balance personalised engagement with #regulatorycompliance? Find out in our webinar brought to you in partnership with @EVERSANAINTOUCH on 31st October 10 am EST. #PharmaMarketing #ppwebinar
https://t.co/LdGgIIZSAX
On PEACE, May explains the acronym, with examples: personalistion, empowerment, acceleration, collaboration, and education. Salmang notes there are a lot of moving parts - how can it be done right, and not just chase a trend? he asks. #ppwebinar @healthware_intl @EVERSANAINTOUCH
#Access, says Calderwood, is a critical consideration. Outside of a hospital setting, not classified as a care team, need to look at the regulations - therefore looked at honorary contracts, as well as privacy statements. #ppwebinar @NIHR_Industry
Thank you for listening. Today's #ppwebinar from @SyneosHealth will be available on demand. Tune in again to hear the conversation on #AI in #clinicaltrials.
https://t.co/dJQAANKvHj
Haring stresses representation of all #patients is so much easier with #AI and #ML for permitting having the #data at a scale that is meaningful - and Zambon agrees. This is all in play right, it 100% has changed, and we progress onwards into the future. #ppwebinar @SyneosHealth
Ask questions, be curious, and try your best - this sums up today's #ppwebinar brought to you by #NIHR, with @TrishnaBharadia, Rosamund Round of @Parexel_London, @Sarah_L_Fallon of @NIHRCRN_gman, and Barbara Molony-Oates of @HRA_Latest, discussing #EDI in #clinicalresearch.
In this latest #ppwebinar brought to you by #NIHR, @Sarah_L_Fallon of @NIHRCRN_gman says many people have more in-depth discussion if can hear thoughts of others. At this, the final poll is: are viewers now optimistic over #EDI becoming central to #clinicalresearch?
In this latest #ppwebinar brought to you by #NIHR, @TrishnaBharadia states #plainlanguage is key. She does a lot of work in this area. Provide an accompanying sheet that explains. @Sarah_L_Fallon of @NIHRCRN_gman mentions group consent, too. #EDI
In this latest #ppwebinar brought to you by #NIHR, it's time for viewer questions. The first on industry collaboration with community outreach seeks elaboration and examples. #EDI
In this latest #ppwebinar brought to you by #NIHR, @TrishnaBharadia says it's the right thing to do, but more importantly the #science demands it. A #business decision also, says Sarah_L_Fallon of @NIHRCRN_gman. There could be unseen harm in products otherwise.
In this latest #ppwebinar brought to you by #NIHR, Rosamund Round of @Parexel_London agrees with the weight of importance on #language. Indeed, locality of terms matter. So continues this discussion of #EDI in #clinicalresearch. Geographic dependent, underserved predominant in UK
In this latest #ppwebinar brought to you by #NIHR, @TrishnaBharadia, Rosamund Round of @Parexel_London, @Sarah_L_Fallon of @NIHRCRN_gman, and Barbara Molony-Oates of @HRA_Latest, discuss EDI in #clinicalresearch.
https://t.co/xVvNItI067
Moderator Eloise McLennan launches a further poll: what is the understanding of NCVR like post the webinar? Results collating, she asks if there is expectation that lead site should liaise with other UK sites? @NIHR_Industry #ppwebinar
From an @NIHR_Industry point of view, this facilitation of joined up conversations is what they are aiming to do. In 2003, there were no iPhones - the tech that existed, of multiple kinds, now permits the necessary connections. A different world. @NIHR_Industry #ppwebinar
When we talk about clinical trials and rare diseases, we don't just mean drugs, says Dr Melita Irving during the #ppwebinar with @IQVIA_global. Biomarkers and wearables need to be validated in the clinical trial setting in order to use them as tools to demonstrate benefit.
In the final poll question, participants indicate believing that the power of genomic technologies to enable broad based genomic testing/newborn screening initiatives will spur the greatest near-term impact in increasing orphan drug dev't & approvals. #ppwebinar @IQVIA_global
In today’s #ppwebinar roundtable, @PTunnah says new comment on #AI being better with a person than in isolation. A question: tech players, and customer experience, what's the impact? @salmaniac steps up, notes his belief in disruption.
In today’s #ppwebinar roundtable, @salmaniac urges more flexible, agile approach. @PTunnah notes resistance to change in the industry though - returns to channel agnosticism, due to investment in heritage channels
Happening today, at 9:30 ET/14:30 GMT/15:30 CET - #ppwebinar with @salmaniac, @PTunnah, and Florent Edouard.
Are #pharma companies ready? Join us tomorrow for a #webinar hosted by @pharmaphorum to explore topics from the whitepaper "Achieving digital enlightenment in 2023 and beyond." Register today! https://t.co/ZP1HLcDhNM
Last Seen Hashtags on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
240.9M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Cristiano Ronaldo
@cristiano
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
97.9M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.2M followers
KATY PERRY
@katyperry
88.3M followers
Taylor Swift
@taylorswift13
82.2M followers
Lady Gaga
@ladygaga
73.7M followers
Virat Kohli
@imvkohli
70.9M followers
Kim Kardashian
@kimkardashian
70.1M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.2M followers
Neymar Jr
@neymarjr
63.8M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.8M followers
Selena Gomez
@selenagomez
61.4M followers
X
@x
60.8M followers